• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cardinal Health Board of Directors Approves Quarterly Dividend

    5/5/25 5:30:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care
    Get the next $CAH alert in real time by email

    DUBLIN, Ohio, May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025.

    Cardinal Health Logo (PRNewsfoto/Cardinal Health)

    About Cardinal Health

    Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom. 

    Contacts

    Media: Erich Timmerman, [email protected] and 614.757.8231

    Investors: Matt Sims, [email protected] and 614.553.3661

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-board-of-directors-approves-quarterly-dividend-302446363.html

    SOURCE Cardinal Health

    Get the next $CAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAH

    DatePrice TargetRatingAnalyst
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    12/13/2024$101.00 → $127.00Underweight → Equal Weight
    Wells Fargo
    12/4/2024$139.00Outperform
    Mizuho
    2/26/2024$125.00Outperform
    Leerink Partners
    More analyst ratings

    $CAH
    SEC Filings

    See more
    • SEC Form 11-K filed by Cardinal Health Inc.

      11-K - CARDINAL HEALTH INC (0000721371) (Filer)

      6/20/25 8:32:15 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form 11-K filed by Cardinal Health Inc.

      11-K - CARDINAL HEALTH INC (0000721371) (Filer)

      6/20/25 8:31:24 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CARDINAL HEALTH INC (0000721371) (Filer)

      6/12/25 6:47:01 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care